WuXi Biologics announces board of directors and committee roles
WuXi Biologics (Cayman) Inc. has announced its board of directors and their respective roles and functions. The executive directors include Dr. Zhisheng Chen, serving as Chief Executive Officer, and Dr. Sherry Xuejun Gu, who holds the position of Chief Technology Officer. Dr. Ge Li is the Chairman, leading the non-executive directors, who also include Mr. Yanling Cao and Ms. Jingwen Miao. The independent non-executive directors are Mr. William Robert Keller, Mr. Kenneth Walton Hitchner III, Mr. Jackson Peter Tai, and Dr. Jue Chen. The announcement also details the composition of the company’s five board committees: Audit, Remuneration, Nomination, Strategy and Environmental, Social and Governance. The chairpersons and members for each committee are also listed. The information was released on June 6, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when WuXi Biologics (Cayman) Inc publishes news
Free account required • Unsubscribe anytime